Kiniksa Pharmaceuticals, Ltd. (KNSA)

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had revenue of $301.77M in the twelve months ending March 31, 2024, with 27.69% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $79.86M with 65.18% year-over-year growth. In the year 2023, Kiniksa Pharmaceuticals had annual revenue of $270.26M with 22.74% growth.

• Revenue (ttm): $301.77M
• Revenue Growth: +27.69%
• P/S Ratio: 5.00
• Revenue / Employee: $1,016,067
• Employees: 297
• Market Cap: 1.51B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	270.26M	50.08M	22.74%
Dec 31, 2022	220.18M	181.64M	471.24%
Dec 31, 2021	38.54M	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	0	-	-
Dec 31, 2017	0	-	-
Dec 31, 2016	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.